Developmental Regulation of Effector and Resident Memory T Cell Generation during Pediatric Viral Respiratory Tract Infection

Thomas J Connors,J Scott Baird,Margot C Yopes,Kyra D Zens,Kalpana Pethe,Thyyar M Ravindranath,Siu-Hong Ho,Donna L Farber,Thomas J. Connors,J. Scott Baird,Margot C. Yopes,Kyra D. Zens,Thyyar M. Ravindranath,Siu-hong Ho,Donna L. Farber
DOI: https://doi.org/10.4049/jimmunol.1800396
2018-05-30
The Journal of Immunology
Abstract:Viral respiratory tract infections (VRTI) remain a leading cause of morbidity and mortality among infants and young children. In mice, optimal protection to VRTI is mediated by recruitment of effector T cells to the lungs and respiratory tract, and subsequent establishment of tissue resident memory T cells (Trm), which provide long-term protection. These critical processes of T cell recruitment to the respiratory tract, their role in disease pathogenesis, and establishment of local protective immunity remain undefined in pediatric VRTI. In this study, we investigated T cell responses in the upper respiratory tract (URT) and lower respiratory tract (LRT) of infants and young children with VRTI, revealing developmental regulation of T cell differentiation and Trm generation in situ. We show a direct concurrence between T cell responses in the URT and LRT, including a preponderance of effector CD8<sup>+</sup> T cells that was associated with disease severity. During infant VRTI, there was an accumulation of terminally differentiated effector cells (effector memory RA<sup>+</sup> T cells) in the URT and LRT with reduced Trm in the early neonatal period, and decreased effector memory RA<sup>+</sup> T cell and increased Trm formation with age during the early years of childhood. Moreover, human infant T cells exhibit increased expression of the transcription factor T-bet compared with adult T cells, suggesting a mechanism for preferential generation of effector over Trm. The developmental regulation of respiratory T cell responses as revealed in the present study is important for diagnosing, monitoring, and treating VRTI in the critical early life stages.
immunology
What problem does this paper attempt to address?